← Leaderboards
Leslie Ina Gold
New York University School Of Medicine
$5,621,772
Attributed
$7,757,267
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,757,267 · 3
By mechanism
R01$4,041,267 · 2
U09$3,716,000 · 1
Top collaborators
- Timothy J Cardozo9 shared
- Bo R Rueda9 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Timothy J Cardozo$14,196,646
- Paolo G. Toniolo$2,811,479
- Anne Zeleniuch-Jacquotte$14,853,206
- Susan Smith$16,159,201
- Maarten C Bosland$10,491,195
Others in their field
Top investigators on “Progesterone”
- William G Barsan · University Of Michigan At Ann Arbor$25,546,111
- Bert W O'Malley · Baylor College Of Medicine$20,446,513
- David W Wright · Virginia Commonwealth University$17,882,898
- Serdar E Bulun · Northwestern University$14,966,619
- Howard N Hodis · University Of Southern California$14,243,539
- Ji-Yong Julie Kim · University Of Illinois At Chicago$13,221,781
Research focus
ProgesteroneEstrogensEndometriumEndometrial CarcinomaEndometrialComplexCessation Of LifeAtypical Endometrial HyperplasiasAffectCancer BiologyCrystallizationCancer TherapyCarcinogenesisBiological AvailabilityCell CycleBiological MarkersCell Cycle ProteinsCell Cycle RegulationBiopsyCell NucleusCell ProliferationCellsCancer CellChemical Group
Grant awards (18)
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$581,460
R01 · FY2018 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$579,879
R01 · FY2017 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$60,511
R01 · FY2017 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$583,157
R01 · FY2016 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$79,392
R01 · FY2016 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$586,799
R01 · FY2015 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$79,392
R01 · FY2015 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$12,996
R01 · FY2015 · CA · contact PI
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer$639,657
R01 · FY2014 · CA · contact PI
DIVISION OF BIOLOGIC, BASIS OF DISEASE SPECIALS$754,000
U09 · FY2005 · RG
DIVISION OF BIOLOGIC, BASIS OF DISEASE SPECIALS$754,000
U09 · FY2005 · RG
DIVISION OF BIOLOGIC, BASIS OF DISEASE SPECIALS$754,000
U09 · FY2005 · RG
DIVISION OF BIOLOGIC, BASIS OF DISEASE SPECIALS$460,000
U09 · FY2005 · RG
DIVISION OF BIOLOGIC, BASIS OF DISEASE SPECIALS$398,000
U09 · FY2005 · RG
DIVISION OF BIOLOGIC, BASIS OF DISEASE SPECIALS$596,000
U09 · FY2004 · RG
Growth Regulation of the Normal &Malignant Endometrium$280,402
R01 · FY2003 · CA
Growth Regulation of the Normal &Malignant Endometrium$279,572
R01 · FY2002 · CA
Growth Regulation of the Normal &Malignant Endometrium$278,050
R01 · FY2001 · CA